Guardant Health to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

Author's Avatar
Aug 06, 2021

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit.